secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2025-05-27T23:59:59+00:00
Accession:  0001104659-25-052959
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Novavax eliminates COO role; John Trizzino to depart June 20, 2025
------------------------------------------------------------------

- COO position eliminated; John Trizzino's employment terminated effective June 20, 2025.
- Separation pay of $601,778 lump sum plus up to 12 months COBRA premiums.
- Consulting agreement June 20 to Dec 31, 2025 at $15,000/month; equity continues vesting during period.
- Unvested options from March 2023 grant will fully vest upon consulting agreement termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000110465925052959/0001104659-25-052959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000110465925052959/tm2516186d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-052959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer